Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug.

'Ecstasy' (3,4-methylenedioxymethamphetamine or MDMA) is a recreational drug that is gaining popularity world wide. There is a paucity of research regarding the ways in which Ecstasy is used and the nature of its effects. A 'snowball' peer network technique was used to recruit 100 users who completed anonymous questionnaires. The research revealed that Ecstasy is primarily used by infrequent recreational drug users for 'fun' at dance parties and social gatherings. The primary reported effects of Ecstasy were a 'positive mood state' and feelings of intimacy and closeness to others. The secondary effects of Ecstasy were the stimulant effects of energy and activation, and the psychedelic effects of insight and perceptual and sensual enhancement. Ecstasy was reported to share the properties of both amphetamines and hallucinogens in the nature of its side effects and residual effects which were no more severe than those of the latter two classes of drug. It appeared Ecstasy was not conductive to regular and frequent use, because tolerance was reported to develop to the positive effects of Ecstasy, while negative effects increased with use. Although few problems associated with the recreational use of Ecstasy have surfaced to date, animal research has shown it to be neurotoxic to serotonergic nerve terminals. Caution must be observed until further research can determine the level of hazard in humans.

[1]  B. Rumack,et al.  A case of MAO inhibitor/MDMA interaction: agony after ecstasy. , 1987, Journal of toxicology. Clinical toxicology.

[2]  C. Moser,et al.  MDMA and human sexual function. , 1986, Journal of psychoactive drugs.

[3]  S. Peroutka,et al.  Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. , 1988, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[4]  A. Shulgin The background and chemistry of MDMA. , 1986, Journal of psychoactive drugs.

[5]  S. Peroutka Ecstasy: The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA , 1990, Topics in the Neurosciences.

[6]  P. Mcguire,et al.  Chronic paranoid psychosis after misuse of MDMA ("ecstasy") , 1991, BMJ.

[7]  J. Langston,et al.  Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration , 1988, Brain Research.

[8]  R. Bost,et al.  'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA. , 1987, JAMA.

[9]  J. Riedlinger The scheduling of MDMA: a pharmacist's perspective. , 1985, Journal of psychoactive drugs.

[10]  D. Nichols,et al.  Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens. , 1986, Journal of psychoactive drugs.

[11]  C. Renfroe MDMA on the street: Analysis Anonymous. , 1986, Journal of psychoactive drugs.

[12]  D. Cooper,et al.  The Sydney AIDS Project: development of acquired immunodeficiency syndrome in a group of HIV seropositive homosexual men. , 1988, Australian and New Zealand journal of medicine.

[13]  J. Osterloh,et al.  Multiple severe complications from recreational ingestion of MDMA ('Ecstasy') , 1987, JAMA.

[14]  J. Newmeyer Some considerations on the prevalence of MDMA use. , 1986, Journal of psychoactive drugs.

[15]  G. Battaglia,et al.  Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[16]  F. Leo Psychotherapy with psychedelic drugs: a case report. , 1981 .

[17]  G. Greer,et al.  Subjective reports of the effects of MDMA in a clinical setting. , 1986, Journal of psychoactive drugs.

[18]  G. Hayner,et al.  MDMA. The dark side of ecstasy. , 1986, Journal of psychoactive drugs.

[19]  R. Riemersma,et al.  "Ecstasy" and sudden cardiac death. , 1988, The American journal of forensic medicine and pathology.

[20]  J. Downing The psychological and physiological effects of MDMA on normal volunteers. , 1986, Journal of psychoactive drugs.

[21]  C. J. Schmidt,et al.  Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. , 1987, The Journal of pharmacology and experimental therapeutics.

[22]  G. Battaglia,et al.  MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons , 1988, Pharmacology Biochemistry and Behavior.

[23]  D. Sweeney,et al.  ECSTACY: A Review of MDMA and MDA , 1987, International journal of psychiatry in medicine.

[24]  R. K. Siegel,et al.  MDMA. Nonmedical use and intoxication. , 1986, Journal of psychoactive drugs.

[25]  J. Bakalar,et al.  Can drugs be used to enhance the psychotherapeutic process? , 1986, American journal of psychotherapy.